Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.

BMC Cancer · 2010 · PMC2991308 · PMID 21050467

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

only marginally significantP = 0.12not close (p > 0.1)

Although only marginally significant, high EGFR low IL12 activity displayed the same trend as in Set1, conferring poor prognosis in ER- breast cancer (HR = 1.86 (0.83-4.17) P = 0.12, Additional file 11 ).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.